Effectiveness and Safety of Golimumab for Patients ≥75 Years Old with Rheumatoid Arthritis

OBJECTIVE: Treatment of elderly patients with rheumatoid arthritis (RA) has been controversial because they often have serious comorbidities and cannot use methotrexate (MTX). In Japan, golimumab (GLM) 100 mg without MTX is approved. We investigated the effectiveness and safety of GLM in elderly pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurosawa, Yoichi, Ito, Satoshi, Sakai, Shunsuke, Hasegawa, Eriko, Kobayashi, Daisuke, Abe, Asami, Otani, Hiroshi, Nakazono, Kiyoshi, Murasawa, Akira, Narita, Ichiei, Ishikawa, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381335/
https://www.ncbi.nlm.nih.gov/pubmed/35850986
http://dx.doi.org/10.2169/internalmedicine.8497-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381335/
https://www.ncbi.nlm.nih.gov/pubmed/35850986
http://dx.doi.org/10.2169/internalmedicine.8497-21

Ejemplares similares